Automated Antimicrobial Susceptibility Testing Market 8.9% CAGR Find Out Growth Potential Through Demand Forecast 2026 | CMI

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Get Sample PDF (Including COVID-19 Impact Analysis, Full TOC, Tables and Figures) of Automated Antimicrobial Susceptibility Testing, https://www.coherentmarketinsights.com/insight/request-pdf/2622

Global Automated Antimicrobial Susceptibility Testing Market, by Product Type (Consumables and Instruments), by Detection Method (Turbidimetric and Colorimetric), by Application (Antibacterial (Tuberculosis and Sepsis), Antifungal, Anti-parasitic, and Anti-viral), by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, and Pathology/Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,295.5 million in 2018 and is estimated to exhibit a CAGR of 8.9% over the forecast period (2018-2026), as highlighted in a new report published by Coherent Market Insights.

The increasing multidrug resistance research, new product launches, and rising number of development programs, coupled with funding are the major factors that are expected to fuel growth of the automated antimicrobial susceptibility testing market over the forecast period.

Moreover, contract research organizations are engaged in performing various research and development activities such as AST and multidrug resistivity testing. Thus, increasing research and development of small molecules by various manufacturing organizations is expected to drive adoption of AST, which is further expected to drive growth of the market over the forecast period. For instance, according to the Cambrex Corporation’s report 2017 on small molecules, small molecules are expected to gain major traction in the pharmaceutical industry, with the approval of 34 new small molecule entities by the U.S. Food and Drug Administration (FDA) in 2017.

Furthermore, major players are focusing on launching susceptibility testing systems in the market, in order to expand their product portfolio and strengthen their position in the global market. For instance, in March 2016, Thermo Fisher Scientific launched antimicrobial susceptibility testing for Tedizolid, allowing microbiology laboratories to perform Tedizolid susceptibility testing of fastidious and non-fastidious Gram positive organisms, which cause acute bacterial skin and skin structure infections (ABSSSIs) in adults. Therefore, increasing launches of such AST testing is expected to drive adoption of susceptibility plates during the forecast period.

Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2622

Moreover, in 2017, bioMérieux launched ETEST Ceftolozane/Tazobactam and ETEST Ceftazidime/Avibactam, which determines the minimum inhibitory concentration (MIC) values necessary to effectively treat infections caused by multidrug resistant organisms.

Additionally, rising numbers of funding for research of antibiotic resistant microbes is expected to further boost the automated antimicrobial susceptibility testing market growth over the forecast period. For instance, in November 2017, Symcel AB, a company engaged in cell-based assay tool for real-time cell metabolism measurements, secured US$ 4.23 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.

Browse 38 Market Data Tables and 25 Figures spread through 200 Pages and in-depth TOC on “Automated Antimicrobial Susceptibility Testing Market, by Product Type (Consumables and Instruments), by Detection Method (Turbidimetric and Colorimetric), by Application (Antibacterial (Tuberculosis and Sepsis), Antifungal, Anti-parasitic, and Anti-viral), by End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals, and Pathology/Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026”

To know the latest trends and insights related to automated antimicrobial susceptibility testing market press release, click the link below: https://www.coherentmarketinsights.com/press-release/automated-antimicrobial-susceptibility-testing-market-to-surpass-us-25549-million-by-2026-1397

Key Takeaways of the Automated Antimicrobial Susceptibility Testing Market:

• The global automated antimicrobial susceptibility testing market is expected to exhibit a CAGR of 8.9% over the forecast period (2018-2026), attributed to increasing research & development and demand for genomic and repertoire sequencing-based research
• On the basis of product type, the consumables segment is expected to account for major market share, in terms of revenue in 2026, attributed to increasing product launches by key players. For instance, in 2016, HiMedia Laboratories introduced its HiCrome Muller Hinton Agar product, which is used for presumptive identification and susceptibility testing.
• Key players operating in the global automated antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.